Loading…
← CockpitCompetitor Analysis › GXI.DE Gerresheimer AGOpen in the cockpit ↗

Gerresheimer AGGXI.DECompetitor analysis, valuation and peers

Germany · EUR·Materials›Containers/Packaging

German maker of glass and plastic packaging and drug-delivery devices such as vials, syringes and bottles for pharma and cosmetics.

≈ A German, packaging-focused smaller West Pharmaceutical ServicesMomentum leader 90
Mkt cap
$1.26B
US dollars, full cap
Free float
100%
of shares outstanding
$/day
$5.54M
20-day average traded
Fwd P/E
16.0×
forward earnings
ROIC−WACC
-7.4 pp
WACC 5.2%
Hurdle
+47 pp
Req g minus delivered
Next earnings
99 days
25 Feb 2027
Close · EUR€33.20
1D+3.8%
1W+4.0%
1M+1.3%
3M+20.3%
6M+21.3%
YTD+20.4%
1Y+37.1%
ATR %3.5%
52w lowhigh2.9% off high

What Gerresheimer does

German maker of glass and plastic packaging and drug-delivery devices such as vials, syringes and bottles for pharma and cosmetics.

Sells packaging and delivery devices that become part of a medicine's regulatory approval, so once a drug is launched in its vial or syringe, switching is slow. Glass-making is energy-hungry, so furnace running costs weigh on margins, and plants need large, ongoing investment.

In one line: A German, packaging-focused smaller West Pharmaceutical Services.

Products and services

  • Pharmaceutical glass vials & syringes
  • Plastic packaging/drug-delivery devices
  • Cosmetics packaging

Customers

  • Pharmaceutical companies
  • Cosmetics/personal care brands

Where it sits in the supply chain

  • Materials
  • Pharma/cosmetics packaging
  • Glass & plastic packaging manufacturing

What could go right

  • GLP-1/injectable drug packaging demand growth
  • Biologics/vaccine packaging demand

What could go wrong

  • Glass/energy input cost inflation
  • Pharma customer destocking cycles

Moat: narrow (regulatory licence, customer qualification, scale). Pharma-grade manufacturing qualifications create high switching costs, but capital-intensive glass/plastic manufacturing is competitive.

Headquarters: Duesseldorf, Germany · Founded: 1864 · Employees: 13,528

Named competitors

Gerresheimer at a glance

Size Gerresheimer (GXI.DE) is a Germany Materials company (Containers/Packaging) with a market value of $1.26B, the 128th largest of 198 Germany companies the cockpit tracks. Shares closed at €33.20 on 18 Nov 2026.

Performance Over six months the shares gained 21.3%, against -2.7% for the median peer and -0.9% for the Germany market (cap-weighted) — 5th highest of 21 in its peer set.

Growth Revenue grew 8.9% over the last twelve months (peer median +0.6%); the operating margin is -4.1% (peer median 7.4%).

Valuation It trades at 16.0× forward earnings against a peer median of 16.2× (10th cheapest of 20).

Price implies For today's price to make sense, revenue must grow about 57% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is +47 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 7.4 points below its cost of capital (5.2% WACC).

Next results Next results expected around 25 Feb 2027 (exchange calendar; dates can move).

Relative performance

9010011012021 May 202621 Aug 202618 Nov 2026GXI.DE 120Peer median 97
Six months, rebased to 100: Gerresheimer against the median of its 20 peers (local-currency closes).

Gerresheimer financials

Reported figures in EUR; fiscal year ends 2025-11-30. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue€2.28B€2.32B€1.99B€1.99B€1.82B
Revenue growth—+17%0%+10%—
Gross profit€348M€495M€502M€551M€500M
EBITDA€434M€377M€358M€396M€350M
Net income-€401M-€320M€82.3M€116M€96.1M
Free cash flow€7.88M-€98.8M-€130M-€33.4M-€15.9M
Capital expenditure€254M€308M€370M€328M€238M
Total debt€2.21B€2.18B€1.28B€1.05B€1.23B

Quarterly statements and history in the cockpit →

Gerresheimer competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-60%-40%-20%0%+20%-20%-10%0%+10%002565ORA7864TRS0022433010936036870029693001519939CAS002014ELOTIMETECHNO600210002787002701002303600529GXI.DE6-month return →1-month return →
Up and to the right = strong over both horizons. Gerresheimer is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%25×50×75×ORA7864TRS0022433010936036870029693001519939CASTIMETECHNO600210002787002701603091600529GXI.DERevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Gerresheimer is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%+60%0%20%40%60%ORA0022433010930029699939CASELO002701603091GXI.DEGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Gerresheimer is the large dot.

Gerresheimer competitors and peer comparison

Head to head with its named competitors (GXI.DE vs WST vs 1SXP.DE vs GLW)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Gerresheimer GXI.DE$1.26B+21%+9%-4%16.0×57.0%
West Pharmaceutical Services WST$28.1B+32%+13%23%40.2×25.8%
SCHOTT Pharma AG & Co. KGaA 1SXP.DE$3.73B+32%+4%15%23.0×12.7%
Corning GLW$93.2B-40%+19%17%25.7×25.6%

How Gerresheimer compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Gerresheimer against its 20 peers (data as of 18 Nov 2026)
MeasureGXI.DEPeer medianRank in peer set
1-month return+1.3%-2.7%8th highest of 21
6-month return+21.3%-2.7%5th highest of 21
Distance from 52-week high-2.9%-33.0%highest of 21
Revenue growth (TTM)+8.9%+0.6%5th highest of 21
Operating margin-4.1%7.4%lowest of 21
Forward P/E16.0×16.2×10th cheapest of 20
Growth the price implies (Req g, 7 yrs)57.0%2.6%most demanding of 12
Growth delivered (Del g)+10.3%+5.5%2nd highest of 12
Hurdle (Req g minus delivered)+46.7 pp+1.6 ppmost demanding of 12
ROIC minus cost of capital-7.4 pp-0.6 pp2nd lowest of 21
EV / EBITDA7.4×7.3×4th most expensive of 8
Net debt / EBITDA4.7×1.6×most indebted of 8

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Gerresheimer GXI.DEGermany$1.26B+21%+9%-4%16.0×57.0%+10.3%
Shanghai Shunho New Materials Technology 002565.SZChina$1.30B-55%-15%-3%n/an/an/a
Orora ORA.AXAustralia$1.30B+21%+6%11%15.4×2.6%-8.9%
Fuji Seal International 7864.TJapan$1.19B+31%+7%9%11.0×n/an/a
TriMas TRSUnited States$1.34B-3%-33%4%19.0×n/an/a
Shenzhen Leaguer 002243.SZChina$1.17B-26%+5%-3%18.5×43.3%+1.6%
Jiangsu Hualan New Pharmaceutical Material 301093.SZChina$1.35B-46%+6%5%68.3×47.9%+6.7%
Zhejiang Great Shengda Packing 603687.SSChina$1.16B-2%+1%3%38.1×n/an/a
Jiamei Food Packaging (Chuzhou) 002969.SZChina$1.41B-63%-10%6%78.2×20.5%+7.3%
Shenzhen Changhong Technology 300151.SZChina$1.12B-26%-1%6%54.7×n/an/a
Taiwan Hon Chuan Enterprise 9939.TWTaiwan$1.07B-6%+1%15%9.7×-4.0%+8.3%
Cascades CAS.TOCanada$1.07B+45%0%5%8.7×-1.0%+3.1%
Huangshan Novel 002014.SZChina$1.04B+4%+9%12%16.2×n/an/a
Elopak ELO.OLNorway$1.01B+8%0%9%12.2×-7.7%+7.7%
Time Technoplast TIMETECHNO.NSIndia$1.00B+10%+21%11%12.1×n/an/a
Shanghai Zijiang Enterprise 600210.SSChina$1.59B+3%-18%10%11.6×n/an/a
Suzhou Hycan 002787.SZChina$996M-40%0%7%33.2×n/an/a
ORG Technology 002701.SZChina$1.62B-20%+24%5%10.2×-5.3%+15.8%
Zhejiang Zhongxin Environmental Protection Technology 603091.SSChina$927M-28%+31%22%13.8×6.8%+4.4%
MYS 002303.SZChina$905M+23%+1%8%18.5×4.9%+3.4%
Shandong Pharmaceutical Glass 600529.SSChina$1.78B+1%-9%18%16.4×-3.0%+5.5%

Questions

Who are Gerresheimer's main competitors?
Named competitors: West Pharmaceutical Services (WST), Schott Pharma (1SXP.DE), Corning (GLW). The cockpit's measured peer set (industry) also includes Shanghai Shunho New Materials Technology (002565.SZ), Orora (ORA.AX), Fuji Seal International (7864.T), TriMas (TRS), Shenzhen Leaguer (002243.SZ), Jiangsu Hualan New Pharmaceutical Material (301093.SZ).
Is Gerresheimer expensive compared with its peers?
On forward p/e it trades at 16.0× against a peer median of 16.2×, 10th cheapest of 20 in its peer set. For today's price to make sense, revenue must grow about 57% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is +47 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Gerresheimer stock performed?
Over six months to 18 Nov 2026 the shares returned +21.3% against -2.7% for the median peer; over one year +37.1%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.